Omeros (NASDAQ:OMER) Given “Buy” Rating at D. Boral Capital
Omeros (NASDAQ:OMER – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at D. Boral Capital in a note issued to investors on Tuesday,Benzinga reports. They presently have a $36.00 price target on the biopharmaceutical company’s stock. D. Boral Capital’s target price suggests a potential upside of 349.44% from the stock’s previous […]
Omeros (NASDAQ:OMER – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at D. Boral Capital in a note issued to investors on Tuesday,Benzinga reports. They presently have a $36.00 price target on the biopharmaceutical company’s stock. D. Boral Capital’s target price suggests a potential upside of 349.44% from the stock’s previous […]
